-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Orthofix Medical, Raises Price Target to $18

Benzinga·11/05/2025 14:31:56
Listen to the news
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price target from $17 to $18.